Skip to main content

Table 4 Multivariate Cox regression analysis of the covariates affecting OS

From: Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study

 

HR

95% CI

p

ΔSMI%* during neoadj. (>median vs. <median)

-0.609

0.297–0.997

0.049

N stage (per level)

0.486

0.940–2.801

0.082

T stage (per level)

0.496

0.993–2.892

0.086

CCI** (per level)

0.175

0.973–1.459

0.091

  1. *The percentual change in skeletal muscle index during neoadjuvant treatments
  2. **Charlson comorbidity index
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us